QUEST DIAGNOSTICS INCORPORATED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 141.2 USD | -0.45% |
|
-0.77% | +2.50% |
| May. 21 | Declaration of Voting Results by Quest Diagnostics Incorporated | CI |
| May. 16 | Quest Diagnostics Elects Robert B. Carte to Board of Directors | CI |
Financials (USD)
| Sales 2024 * | 9.45B | Sales 2025 * | 9.76B | Capitalization | 15.76B |
|---|---|---|---|---|---|
| Net income 2024 * | 894M | Net income 2025 * | 962M | EV / Sales 2024 * | 2.1 x |
| Net Debt 2024 * | 4.09B | Net Debt 2025 * | 3.51B | EV / Sales 2025 * | 1.97 x |
| P/E ratio 2024 * |
18.2
x | P/E ratio 2025 * |
16.7
x | Employees | 44,000 |
| Yield 2024 * |
2.08% | Yield 2025 * |
2.1% | Free-Float | 68.24% |
More Fundamentals
* Assessed data
More news
Latest transcript on Quest Diagnostics Incorporated
More recommendations
More press releases
More news
| 1 day | +0.61% | ||
| 1 week | +0.24% | ||
| Current month | +3.33% | ||
| 1 month | +4.44% | ||
| 3 months | +12.35% | ||
| 6 months | +5.34% | ||
| Current year | +3.55% |
1 week
140.13
145.62
1 month
134.05145.62
Current year
123.04145.62
1 year
119.59145.62
3 years
119.59174.16
5 years
73.02174.16
10 years
56.27174.16
| Managers | Title | Age | Since |
|---|---|---|---|
James Davis
CEO | Chief Executive Officer | 61 | 13-03-31 |
Sam Samad
DFI | Director of Finance/CFO | 54 | 22-07-10 |
Kristin Wallace
CMP | Compliance Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Denise Morrison
BRD | Director/Board Member | 70 | 19-02-17 |
Timothy Ring
BRD | Director/Board Member | 66 | 11-12-06 |
Gary Pfeiffer
BRD | Director/Board Member | 74 | 04-11-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 14.84% | 254 M€ | +12.33% | - | |
| 2.17% | 2 M€ | 0.00% | ||
| 2.05% | 8 M€ | 0.00% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-23 | 141.3 | -0.37% | 355 912 |
| 24-05-22 | 141.9 | -1.03% | 805,651 |
| 24-05-21 | 143.3 | -0.58% | 561,764 |
| 24-05-20 | 144.2 | -0.12% | 1,078,786 |
| 24-05-17 | 144.3 | +1.34% | 1,422,833 |
Delayed Quote Nyse, May 23, 2024 at 12:25 pm EDT
More quotes
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
141.9
USD
Average target price
146.8
USD
Spread / Average Target
+3.48%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.55% | 15.76B | |
| +17.09% | 83.4B | |
| -27.81% | 72.11B | |
| 0.00% | 27.04B | |
| -12.02% | 16.96B | |
| +1.03% | 16.86B | |
| +73.75% | 13.33B | |
| +1.74% | 12.76B | |
| +72.70% | 12.74B | |
| +1.11% | 12.32B |
- Stock Market
- Equities
- DGX Stock
